Gene expression analysis in mesothelioma cell lines with and without K-975 treatment
RNA-seq (gene expression) · human · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- MesotheliomaThis series is part of our curated briefing on it.
- Samples
- 36 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE262853_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1093486 and SRA study SRP498760. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 12 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8180506 MSTO_control_rep1 MSTO_control
- GSM8180507 MSTO_control_rep2 MSTO_control
- GSM8180508 MSTO_control_rep3 MSTO_control
- GSM8180509 MSTO_K975_rep1 MSTO_K975
- GSM8180510 MSTO_K975_rep2 MSTO_K975
- GSM8180511 MSTO_K975_rep3 MSTO_K975
- GSM8180512 H2052_control_rep1 H2052_control
- GSM8180513 H2052_control_rep2 H2052_control
- GSM8180514 H2052_control_rep3 H2052_control
- GSM8180515 H2052_K975_rep1 H2052_K975
- GSM8180516 H2052_K975_rep2 H2052_K975
- GSM8180517 H2052_K975_rep3 H2052_K975
- GSM8180518 ACC1_control_rep1 ACC1_control
- GSM8180519 ACC1_control_rep2 ACC1_control
- GSM8180520 ACC1_control_rep3 ACC1_control
- GSM8180521 ACC1_K975_rep1 ACC1_K975
- GSM8180522 ACC1_K975_rep2 ACC1_K975
- GSM8180523 ACC1_K975_rep3 ACC1_K975
- GSM8180524 Y27_control_rep1 Y27_control
- GSM8180525 Y27_control_rep2 Y27_control
- GSM8180526 Y27_control_rep3 Y27_control
- GSM8180527 Y27_K975_rep1 Y27_K975
- GSM8180528 Y27_K975_rep2 Y27_K975
- GSM8180529 Y27_K975_rep3 Y27_K975
- GSM8180530 MSTO KR_control_rep1 MSTO KR_control
- GSM8180531 MSTO KR_control_rep2 MSTO KR_control
- GSM8180532 MSTO KR_control_rep3 MSTO KR_control
- GSM8180533 MSTO KR_K975_rep1 MSTO KR_K975
- GSM8180534 MSTO KR_K975_rep2 MSTO KR_K975
- GSM8180535 MSTO KR_K975_rep3 MSTO KR_K975
- GSM8180536 H2052 KR_control_rep1 H2052 KR_control
- GSM8180537 H2052 KR_control_rep2 H2052 KR_control
- GSM8180538 H2052 KR_control_rep3 H2052 KR_control
- GSM8180539 H2052 KR_K975_rep1 H2052 KR_K975
- GSM8180540 H2052 KR_K975_rep2 H2052 KR_K975
- GSM8180541 H2052 KR_K975_rep3 H2052 KR_K975
- GSE305915 Generating Revitalized Stem Cell-Engineered CAR-NKT Cells for the Treatment of Malignant Pleural Mesothelioma 1 samples same disease briefing · shares mesothelioma, treatment
- GSE250038 Gene expression data from precision cut tumor slices from head and neck or mesothelioma tumors 26 samples same disease briefing · shares mesothelioma
- GSE327167 Single-cell RNA-seq profiling of pleural mesothelioma and comparator pleural specimens 113 samples same disease briefing · shares mesothelioma
- GSE272176 PD-1 blockade mitigates surgery-induced immunosuppression and increases the efficacy of photodynamic therapy for malignant pleural mesothelioma 82 samples same disease briefing · shares mesothelioma
- GSE274983 Soluble Mesothelin-Related Peptide as a Prognosticator in Pleural Mesothelioma Patients Receiving Checkpoint Immunotherapy 18 samples same disease briefing · shares mesothelioma
- GSE282239 A new soluble CSF1R-dimeric mutein with enhanced trapping of both CSF-1 and IL-34 reduces suppressive tumor-associated macrophages in mesothelioma. 12 samples same disease briefing · shares mesothelioma
- GSE292620 Genome-wide CRISPR Screen Identifies BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma 12 samples same disease briefing · shares mesothelioma
- GSE326187 Combined dopamine receptor inhibition and radiotherapy target mesothelioma-initiating cells and increase survival in a mouse model of mesothelioma 12 samples same disease briefing · shares mesothelioma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.